Could CBD Be An Antibiotic?

The relationship between infection and traditional antibiotics

Could CBD work in the fight versus resistant bacterial pressures? The arise from the University of Queensland in Australia recommend that it is possible. However prior to taking a look at the research study in depth, it is useful to comprehend the development of the relationship between bacteria and antibiotics.

Since the advanced discovery of penicillin by Alexander Fleming in 1928, antibiotics have actually been an important tool in the fight versus bacteria and infections. And although we still utilize the same proven techniques today, bacteria have actually evolved. When exposed to antibiotics, certain bacteria, fungis and parasites are able to adjust and cancel the efficiency of the drug by developing resistance.

It’s worth mentioning that antimicrobial resistance was most likely to occur anyway, as the hereditary code for bacteria changes in time. However, it is thought that the overuse of antibiotics is an essential factor that speeds up the advancement of resistant pressures. See Nine CBD for further reading.

According to the World Health Organization, antimicrobial resistance “is a significantly severe risk to international public health that needs action in all sectors of federal government and in society.” This has actually led researchers to think outside the box by attempting to determine substances that could be useful in the fight versus hazardous bacteria. Among these substances is cannabidiol (CBD), a cannabinoid discovered in Cannabis sativa.

Researchers are trying to find new methods to attack infections and resistant bacteria.

Dr. Mark Blaskovich, Principal Investigator and Program Coordinator for the Community for Open Antimicrobial Drug Discovery and Senior Research Officer at the Institute for Molecular Bioscience at the University of Queensland, concluded that CBD is effective versus Gram-positive bacteria. Strains of Gram-positive bacteria consist of Staphylococcus aureus (common in skin infections) and Streptococcus pneumoniae (common in bacterial pneumonia). CBD Gurus is a good resource for this.

Dr. Blaskovich presented his findings at a yearly conference of the American Society for Microbiology. In vitro samples of both types of gram-positive bacteria were treated with artificial CBD. The results led Dr. Blaskovich to the conclusion that CBD operates at levels comparable to those of prescription antibiotics vancomycin and daptomycin. He also found that CBD appeared to work against gram-positive pressures of resistant bacteria, which numerous standard antibiotics are starting to fail.

” In particular, the activity was picked versus the resistant pressures of Staphylococcus aureus (MRSA, VISA, SARV), Streptococcus pneumoniae (MDR), and Enterococcus faecalis (ERV). Cannabidiol was bactericidal, had a low propensity to induce resistance and was active versus MRSA biofilms. “

The group also conducted another research study utilizing topical CBD to deal with a skin infection in mice. Again, although the results were positive, CBD did not appear to eliminate the infection, however simply to reduce the number of bacterial cells.

Could CBD become an antibiotic?

While it is easy to hail this work as a substantial advancement in the anti-bacterial capabilities of CBD, it is prematurely to give up on penicillin.

Although it is thought that the efficiency of CBD could come from the way it attacks the biofilm surrounding bacterial cells, the authors are still uncertain of the mechanism of action of CBD. They also did not think twice to mention the shortcomings of the research study. Dr. Blaskovich mentioned that because the results are in the initial phases, it is far too early for people to begin treating their CBD infections themselves.

The research study was also conducted in vitro (outside the human body), and there is a risk that the results of medical trials will not be the same. Several substances have actually revealed anti-bacterial efficacy in petri dishes, however then stopped working at this crucial phase. It needs to also be mentioned that the two studies were performed in collaboration with Botanix Pharmaceuticals Ltd, a pharmaceutical business focusing on topical CBD products.

However, this research could be an essential step forward for CBD and the fight versus antimicrobial resistance. CBD continues to have a great safety profile and is not considered poisonous even in big amounts. Fortunately, Dr. Blaskovich and his group strategy to continue their research.

Scroll to top